Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Immune Response and Inflammation, and Vector-borne infectious diseases.
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM
Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials
Treatment Outcomes Among Patients With a Positive<i>Candida</i>Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study
Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial
Risk Factors for Intra-Abdominal Candidiasis in Intensive Care Units: Results from EUCANDICU Study
EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
147. Clinical Safety and Efficacy of Novel Antifungal, Fosmanogepix, in the Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the <scp>FUN</scp>gal infections Definitions in <scp>ICU</scp> patients (<scp>FUNDICU</scp>) project
Intensive care medicine research agenda on invasive fungal infection in critically ill patients
International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus
Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia
Role of autophagy genetic variants for the risk of Candida infections
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans
Autophagy is redundant for the host defense against systemic Candida albicans infections
Candida albicans Infection Affords Protection against Reinfection via Functional Reprogramming of Monocytes
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients
Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials
ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures
ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)
Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia
Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis